Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

RITE AID CORPORATION

(RAD)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Rite Aid : Subsidiary Elixir Names Lance Neill Chief Operating Officer

09/07/2021 | 12:56pm EDT


© MT Newswires 2021
All news about RITE AID CORPORATION
10/05RITE AID : Management's Discussion and Analysis of Financial Condition and Results of Cont..
AQ
10/02RITE AID : Pharmacies face 1st trial over role in opioid crisis
AQ
10/01Pharmacy chains face first trial in U.S. opioid litigation, judge urges settlement
RE
09/24RITE AID : Statement on CDC Recommendation Regarding COVID-19 Vaccine “Boosters&rdqu..
BU
09/24RITE AID : Expands Partnership With Uber to Deliver Products Across US Via Uber Eats
MT
09/24RITE AID : Partners With Uber Eats to Expand On-Demand Delivery Nationwide
BU
09/24Rite Aid Partners With Uber Eats to Expand On-Demand Delivery Nationwide
CI
09/24Rite Aid Expands Partnership With Uber
DJ
09/23Salesforce.com, Darden rise; Steelcase, Rite Aid fall
AQ
09/23RITE AID : Swings to Fiscal Q2 Adjusted Loss; Revenue Advances
MT
More news
Analyst Recommendations on RITE AID CORPORATION
More recommendations
Financials (USD)
Sales 2022 25 131 M - -
Net income 2022 -185 M - -
Net Debt 2022 2 974 M - -
P/E ratio 2022 -3,98x
Yield 2022 -
Capitalization 739 M 739 M -
EV / Sales 2022 0,15x
EV / Sales 2023 0,09x
Nbr of Employees 50 000
Free-Float 97,2%
Chart RITE AID CORPORATION
Duration : Period :
Rite Aid Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends RITE AID CORPORATION
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 3
Last Close Price 13,63 $
Average target price 12,67 $
Spread / Average Target -7,07%
EPS Revisions
Managers and Directors
Heyward R. Donigan President, Chief Executive Officer & Director
Matthew C. Schroeder Chief Financial Officer & Executive Vice President
Bruce G. Bodaken Chairman
Justin Mennen Chief Information Officer & Executive VP
Lance Neill Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
RITE AID CORPORATION-13.90%739
RAIA DROGASIL S.A.-11.10%6 601
AIN HOLDINGS INC.5.65%2 076
PETMED EXPRESS, INC.-15.03%550
QOL HOLDINGS CO., LTD.43.91%520
HLS THERAPEUTICS INC.7.33%506